PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Drug Discovery: Solving the Structure of an Anti-hypertension Drug Target
July 2015
Retrospective: 7,000 Structures Closer to Understanding Biology
July 2015
Design and Evolution: Bespoke Design of Repeat Proteins
June 2015
Design and Evolution: Molecular Sleuthing Reveals Drug Selectivity
June 2015
Design and Evolution: Tunable Antibody Binders
June 2015
Design and Evolution: Unveiling Translocator Proteins
June 2015
Evolution of Photoconversion
June 2015
Families in Gene Neighborhoods
June 2015
Protein Folding and Misfolding: A TRiC-ster that Follows the Rules
March 2015
Protein Folding and Misfolding: Beneficial Aggregation
March 2015
Peptidyl-carrier Proteins
October 2014
Predicting Protein Crystal Candidates
October 2014
Protein and Peptide Synthesis: Coming Full Circle
October 2014
Protein and Peptide Synthesis: Sensing Energy Balance
October 2014
Mining Protein Dynamics
May 2014
Novel Proteins and Networks: Assigning Function
May 2014
Novel Proteins and Networks: Polysaccharide Metabolism in the Human Gut
May 2014
Design and Discovery: Evolutionary Dynamics
January 2014
Design and Discovery: Identifying New Enzymes and Metabolic Pathways
January 2014
Design and Discovery: Virtual Drug Screening
January 2014
Caught in the Act
December 2013
Microbiome: Insights into Secondary Bile Acid Synthesis
September 2013
Microbiome: Structures from Lactic Acid Bacteria
September 2013
The Immune System: A Brotherhood of Immunoglobulins
June 2013
The Immune System: Super Cytokines
June 2013
Design and Discovery: A Cocktail for Proteins Without ID
February 2013
Design and Discovery: Enzyme Reprogramming
February 2013
Design and Discovery: Extreme Red Shift
February 2013
Design and Discovery: Flexible Backbone Protein Redesign
February 2013
Designer Proteins
February 2013
Membrane Proteome: Sphingolipid Synthesis Selectivity
December 2012
Symmetry from Asymmetry
October 2012
Serum albumin diversity
August 2012
Pocket changes
July 2012
Predictive protein origami
July 2012
Targeting Enzyme Function with Structural Genomics
July 2012
Finding function for enolases
June 2012
Substrate specificity sleuths
April 2012
Disordered Proteins
February 2012
Metal mates
February 2012
Making invisible proteins visible
October 2011
Alpha/Beta Barrels
October 2010
Deducing function from small structural clues
February 2010
Extremely salty
February 2010
Membrane proteins spotted in their native habitat
January 2010
How does Dali work?
December 2009
Secretagogin
December 2009
Designing activity
September 2008

Research Themes Protein design

Drug Discovery: Solving the Structure of an Anti-hypertension Drug Target

SBKB [doi:10.1038/sbkb.2015.22]
Featured Article - July 2015
Short description: Serial femtosecond crystallography is used to solve the structure of angiotensin II type 1 receptor.


The structure of human AT1R bound to an antagonist is solved using serial femtosecond crystallography with X-ray free-electron laser. Reprinted from ref. 1, permission granted by Elsevier, 2015.

Cardiovascular disease is one of the leading causes of death worldwide, and has therefore been the focus of considerable effort and advances in drug discovery. Hypertension is the main risk factor for cardiovascular disease, and the G protein-coupled receptor (GPCR) angiotensin II type 1 receptor (AT1R) is an important target for anti-hypertensive drugs, known as AT1R blockers or ARBs. However, the lack of structural data for how ARBs bind AT1R has hampered development and rational optimization of these drugs.

Now Cherezov and colleagues (PSI GPCR Network and MPID) have taken advantage of new methodology to elucidate the structure of AT1R, an achievement previously prevented by the size of the crystals formed by this protein, which are exceedingly small. Luckily, this is not a problem when using the serial femtosecond crystallography technique, which allowed solving the structure of AT1R (PDB 4YAY) to a resolution of 2.9 Å, using crystals that were only 10 × 2 × 2 μm in size. Over 70,000 indexed protein crystal patterns were needed to solve the structure, collected using synchrotron radiation focused on tiny crystals grown in a matrix that mimics the cell membrane.

Overall, the structure of the protein is similar to other peptide-binding GPCRs, including chemokine receptors and opioid receptors. Perhaps more interestingly, the structure was solved with an ARB (ZD7155) bound in the ligand-binding pocket, and most of the important residues for this interaction are not conserved in other GPCRs. Thus, the ligand-binding pocket is unique and requires specific inhibitors.

Molecular modelling of other ARBs into the ligand-binding site of AT1R showed that most compounds bound in similar orientations. These interactions should now be the starting point for structure-based drug design and, hopefully, more effective and specific anti-hypertension agents.

Rebecca Kirk

References

  1. H. Zhang et al. Structure of the angiotensin receptor revealed by serial femtosecond crystallography.
    Cell. 161, 833-844 (2015). doi:10.1016/j.cell.2015.04.011

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health